UCL launches neurodegeneration PhD and clinical fellowship programme
15 October 2012
The Leonard Wolfson Experimental Neurology Centre (LWENC) at UCL recently launched a new 4 year PhD and 3-4 year clinical fellowship programme in neurodegeneration.
The programme hopes to attract students and researchers with a strong interest in using interdisciplinary approaches to address a wide variety of questions in neurodegeneration research, and will provide them with an unrivalled opportunity to participate in cutting-edge research under the supervision of world-class basic science and clinical researchers.
The programme is funded through a £20million Wolfson Foundation grant, which was awarded to a team of UCL Institute of Neurology scientists in December 2012 to set up the Leonard Wolfson Experiment Neurology Centre at UCL. The Centre, which is scheduled to open in summer 2013 and accept its first intake of students and fellows in 2013/14, is a dedicated, specialist centre for the conduct of first-in-human studies of novel therapies for the treatment of neurodegenerative diseases.
Co-chair of LWENC Education Working Group, Professor Nicholas Wood commented: "Our aim is for this programme to provide world class training in a purpose built environment to produce future leaders in innovative neurodegenerative research."
The PhD and Clinical fellowship programme is additionally supported by a generous contribution of £1.25million from the global pharmaceutical company Eisai.
For more information about the Leonard Wolfson Clinical Fellowship and PhD Programme in Neurodegeneration, please see http://www.ucl.ac.uk/lwenc/fellowshipphdprogramme
- Leonard Wolfson Experimental Neurology Centre (LWENC)
- UCL Institute of Neurology
- UCL Neuroscience
- The Wolfson Foundation